Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Quality of Life After Radical Cavity Revision and Obliteration With S53P4 Bioactive Glass Granules

NCT07496112 is registered in ClinicalTrials.gov with Azienda Socio Sanitaria Territoriale Ovest Milanese, Ospedale di Legnano as lead sponsor.

NCT NCT07496112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07496112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Quality of Life After Radical Cavity Revision and Obliteration With S53P4 Bioactive Glass Granules
Lead sponsor
Azienda Socio Sanitaria Territoriale Ovest Milanese, Ospedale di Legnano
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 1, 2025
Completion date
May 15, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tympanoplasty